The latest OVATION-2 trial update, presented at the American Society of Clinical Oncology 2025 annual meeting, shows that adding intraperitoneal IMNN-001 to standard neoadjuvant chemotherapy improved both...
A phase II trial evaluating pembrolizumab plus lenvatinib in clear cell ovarian carcinoma shows promising response rates and 6-month progression-free survival.
A retrospective analysis from Memorial Sloan Kettering links higher patient-reported pain to increased emergency department utilization among individuals newly diagnosed with ovarian cancer. This study was...
Secretary Robert F. Kennedy Jr. announced that the CDC will no longer recommend the COVID-19 booster vaccine for healthy children and pregnant people. The announcement comes despite previous CDC...
A clinical trial found hysteroscopic resection may improve outcomes for progestin-resistant atypical hyperplasia or grade 1 endometrial cancer in select patients. This study was presented at the Society of...
Virtual reality shows benefits in reducing both pain and anxiety across multiple clinical OBGYN settings, according to the results of a recent systematic review presented at the 2025 ACOG Annual Clinical...
A novel hysterectomy technique may offer faster recovery and less pain for patients with benign gynecologic conditions. New data presented at 2025 ACOG Annual Clinical & Scientific Meeting in...
In a novel organ-on-chip model, aspirin demonstrated protective effects on placental cells under inflammatory conditions, while indomethacin was associated with increased cytotoxicity across all cell types....
In this interview, Neal Skolnik, MD, previews his Practical Updates in Primary Care 2025 presentation on evolving approaches to UTI management, including updated diagnostic guidance, emerging antibiotic...
Real-world data show a rise in biomarker testing for primary advanced/recurrent endometrial cancer, especially mismatch repair/microsatellite instability, but disparities in access persist across care...
